Sri Lekha Tummalapalli

The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Michael G. Shlipak, Sri Lekha Tummalapalli, L. Ebony Boulware et al. · Kidney International · 2020 · 573 citations · Full text

Medicine, Health Policy, Nephrology +17

Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System

Julio A. Lamprea‐Montealegre, Erin Madden, Sri Lekha Tummalapalli et al. · JAMA · 2022 · 126 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Trends in Quality of Care for Patients with CKD in the United States

Sri Lekha Tummalapalli, Neil R. Powe, Salomeh Keyhani · Clinical Journal of the American Society of Nephrology · 2019 · 56 citations · Full text

Public Affairs, Chronic Disease Control, Health Care Quality Management +16

Prescribing Patterns of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD: A Cross-Sectional Registry Analysis

Min Zhuo, Jiahua Li, Leo F. Buckley et al. · Kidney360 · 2022 · 49 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +15

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease

Julio A. Lamprea‐Montealegre, Erin Madden, Sri Lekha Tummalapalli et al. · Diabetes Care · 2022 · 46 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17